The Beatrice Hunter Cancer Research Institute logo
  • Dr. Pier Jr Morin, PhD, MBA

Appointments:

Associate Professor – Biochemistry, Department of Chemistry and Biochemistry, Université de Moncton; Adjunct Professor – Biochemistry, Department of Biochemistry, Université de Sherbrooke                            

Affiliations:

Université de Moncton (primary)
Université de Sherbrooke (cross-appointment)

Research Interests:

Cellular signaling, kinases, brain tumours, glioblastomas

Targeting the kinome in glioblastomas

Glioblastoma multiforme (GBM) is an aggressive brain tumor for which current therapeutic approaches are limited.  Dr. Morin and his research team focus on the identification of hyperactivated signaling pathways involved in the biogenesis and development of GBMs and which could serve as sites for targeted therapeutic intervention.  Differentially regulated protein kinases, key mediators of signal transduction and druggable targets, are characterized in primary GBM tumours and cell lines.

Membership Status:

Dr. Morin is a BHCRI Associate Member.

Phone:

(506) 858-4355

Email:

pier.morin@umoncton.ca

Address:

Rémi Rossignol building, Université de Moncton, 18 Antonine-Maillet avenue, Moncton, New Brunswick, Canada, E1A 3E9

Publications:

Kinley, S., St-Coeur, P-D, Vogels, C.M., Decken, A., Morin, P. Jr. et Westcott, S.A. (2017) Synthesis, characterization, and anticancer properties of iminophosphineplatinum(II) complexes containing boronate esters. Can. J. Chem. 95: 207-213.
 
St-Coeur, P-D, Poitras, J.J., Cuperlovic-Culf, M., Touaibia, M. et Morin, P. Jr. (2015) Investigating a signature of temozolomide resistance in GBM cell lines using metabolomics. J. Neurooncol. 125: 91-102.   
 
LeBlanc, V.C. et Morin, P. Jr. (2015) Exploring miRNA-associated signatures with diagnostic relevance in glioblastoma multiforme and breast cancer patients. J. Clin. Med. 4: 1612-1630.

Patterson, A.E., Miller, J.J., Miles, B.A., Stewart, E.L., Melanson, E.J., Vogels, C.M., Cockshutt, A.M., Decken, A., Morin, P. Jr. et Westcott, S.A. (2014) Synthesis, characterization and anticancer properties of (salicylaldiminato)platinum(II) complexes. Inorganica Chim. Acta. 415 : 88-94.

Lang-Ouellette, D. et Morin, P. Jr. (2014) Differential expression of miRNAs with metabolic implications in hibernating thirteen-lined ground squirrels, Ictidomys tridecemlineatus. Mol. Cell. Biochem. 394: 291-298.   

St-Coeur, P-D, Touaibia, M., Cuperlovic-Culf, M. et Morin, P. Jr. (2013) Leveraging metabolomics to assess the next generation of temozolomide-based therapeutic approaches for glioblastomas. Genomics, Proteomics & Bioinformatics. 11: 199-206.

Morin, P. Jr., Ferguson, D., LeBlanc, L., Hébert, M., Paré, A., Jean-François, J., Surette, M., Touaibia, M. et Cuperlovic-Culf, M. (2013) NMR metabolomics analysis of the effects of 5-lipoxygenase inhibitors on metabolism in glioblastomas. J. Proteome Res. 12: 2165-2176.

Cuperlovic-Culf, M., Culf, A.S., Morin, P. Jr. et Touaibia, M. (2013) Application of metabolomics in drug discovery, development and theranostics. Curr. Metabol. 1: 41-57.

Lyons, P.J., Poitras, J.J., Courteau, L.A., Storey, K.B. et Morin, P. Jr. (2013) Identification of differentially regulated microRNAs in cold-hardy insects. Cryo Letters. 34: 83-89.

St-Coeur, P-D, Ferguson, D., Morin, P. Jr. et Touaibia, M. (2013) PF-8380 and closely related analogues synthesis, structure-activity relationship towards autotaxin inhibition and glioma cell viability. Archiv. Pharm. Chem. Life Sci. 346: 91-97.

Site by: Spectacle Group